Shannon John Patrick Jr

CIK 00015535953 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001553595

Recent Transactions

50 trades

Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2026-01-05$1.55/sh+64,265→ 2,769,611 total
Sale
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2026-01-05$7.08/sh−24,907→ 2,705,346 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2026-01-05−2,900→ 97,100 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2026-01-05−25,136→ 0 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2026-01-05−64,265→ 0 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2026-01-05$3.94/sh+2,900→ 2,797,647 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2026-01-05$1.55/sh+25,136→ 2,794,747 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2025-11-14−87,100→ 64,265 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-11-14$1.55/sh+87,100→ 2,730,253 total
Sale
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-11-13$7.46/sh−23,242→ 2,643,153 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2025-11-13−8,970→ 151,365 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-11-13$1.55/sh+8,970→ 2,666,395 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-08-01$5.38/sh−36,918→ 2,657,425 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-31+800,000→ 2,687,118 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Appreciation Right
2025-01-31+600,000→ 600,000 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-31$3.56/sh−110,750→ 1,997,868 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-31$3.56/sh−110,750→ 1,887,118 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-03$3.61/sh−39,443→ 2,108,618 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-08-01+250,000→ 2,419,612 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Appreciation Right
2024-08-01+300,000→ 300,000 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-31$2.46/sh−110,750→ 2,148,061 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-31+750,000→ 2,158,575 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-29$2.66/sh−22,150→ 2,258,811 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-03$2.24/sh−40,834→ 2,280,961 total
Purchase
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-11-17$1.64/sh+30,769→ 1,408,575 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-31$1.24/sh−9,880→ 2,321,795 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-31+750,000→ 1,377,806 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-29$1.26/sh−23,414→ 2,331,675 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-03$1.12/sh−41,334→ 2,355,089 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-31$2.11/sh−7,497→ 2,396,423 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-29$2.11/sh−15,692→ 2,403,920 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-03+250,000→ 618,910 total
Purchase
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-11-12$2.10/sh+60,000→ 363,829 total
Purchase
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-11-11$2.09/sh+40,000→ 303,829 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−193,333→ 0 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+160,335→ 160,335 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+28,072→ 28,072 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+193,333→ 263,829 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+34,977→ 34,977 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+25,136→ 25,136 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+80,000→ 80,000 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+100,000→ 100,000 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−34,977→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−28,072→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−160,335→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−100,000→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−80,000→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−25,136→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−70,496→ 193,333 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+70,496→ 70,496 total

Companies

Recent Filings

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607

View on SEC.gov